AVD on NYSE
AMERICAN VANGUARD CORP
Price unavailable
Last updated Oct 16, 2026.
Overview
Compare with CVR PARTNERS, LP, Bioceres Crop Solutions Corp. or The Scotts Miracle-Gro Company, or pick any stock.
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
28.6%Gross margin3
-5.5%Operating margin3
-9.7%Net margin3
-5.9%Revenue growth, 20253
-25.9%Return on equity3
0.90×Debt to equity3
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
US Crop brought in 71% of the revenue AMERICAN VANGUARD CORP broke down this way in fiscal 2025.
Products and services by year
| Products and services | 2023 | 2024 | 2025 |
|---|---|---|---|
| US Crop | $269.2M | $228.3M | $221.4M |
| US Non-Crop | $75.3M | $82.4M | $90.3M |
Regions
United States brought in 62% of the revenue AMERICAN VANGUARD CORP broke down this way in fiscal 2025.
Regions by year
| Regions | 2023 | 2024 | 2025 |
|---|---|---|---|
| United States | $344.5M | $310.7M | $311.7M |
| South and Central America | $117.7M | $118.2M | $119.0M |
| Mexico | $49.8M | $48.5M | $43.2M |
| Australia | $19.7M | $21.7M | $15.7M |
| Canada | $12.3M | $8.5M | $8.8M |
| Europe | $2.2M | $1.9M | $1.8M |
| Africa | $3.7M | $5.6M | $1.4M |
| Middle East | $1.4M | $739.0K | $732.0K |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue70¢$367.6M
- Research and development4¢$23.2M
- Selling, general and admin21¢$110.6M
- Interest4¢$18.5M
- Income tax1¢$2.7M
Out of $515.1M in revenue.3 The company lost money this year.
Financial statements
Every line of the income statement in the latest annual report, as filed.3
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net sales | $515.1M | $547.3M | $579.4M |
| Cost of sales | -$367.6M | -$427.0M | -$400.2M |
| Gross profit | $147.6M | $120.3M | $179.2M |
| Selling, general and administrative | -$110.6M | -$119.6M | -$116.9M |
| Research, product development and regulatory | -$23.2M | -$32.7M | -$38.0M |
| Product liability claims | -$9.7M | $0 | $0 |
| Transformation | -$7.2M | -$20.2M | -$957.0K |
| Asset impairment | -$25.4M | -$50.4M | $0 |
| Gain from sale of assets | $249.0K | $1.0M | $0 |
| Operating (loss) income | -$28.3M | -$101.6M | $23.3M |
| Change in fair value of equity investments, net | -$437.0K | -$2.4M | -$359.0K |
| Interest and other interest expenses, net | -$18.5M | -$16.5M | -$12.6M |
| (Loss) income before provision for income taxes | -$47.2M | -$120.5M | $10.3M |
| Provision for income taxes | -$2.7M | -$5.9M | -$2.8M |
| Net (loss) income | -$49.9M | -$126.3M | $7.5M |
| (Losses) earnings per common sharebasic | -$1.75 | -$4.50 | $0.27 |
| (Losses) earnings per common shareassuming dilution | -$1.75 | -$4.50 | $0.26 |
| Weighted average shares outstandingbasic | 28.4M shares | 28.1M shares | 28.1M shares |
| Weighted average shares outstandingassuming dilution | 28.4M shares | 28.1M shares | 28.5M shares |
Every line of the balance sheet in the latest annual report, as filed.3
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash | $12.4M | $12.5M | $11.4M |
| Trade, net of allowance for credit losses of $11,733 and $9,190 respectively | $160.5M | $169.7M | |
| Other | $7.3M | $4.7M | |
| Total receivables, net | $167.8M | $174.4M | |
| Inventories | $176.0M | $179.3M | |
| Prepaid expenses and other assets | $9.7M | $7.6M | |
| Income taxes receivable | $4.6M | $5.0M | |
| Total current assets | $370.5M | $378.9M | |
| Property, plant and equipment, net | $53.0M | $58.2M | |
| Operating lease right-of-use assets, net | $16.8M | $19.7M | |
| Intangible assets, net | $138.7M | $150.5M | $172.5M |
| Goodwill | $0 | $19.7M | $51.2M |
| Deferred income tax assets | $2.6M | $1.2M | |
| Other assets | $14.8M | $8.5M | |
| Total assets | $596.5M | $636.7M | |
| Accounts payable | $87.5M | $69.2M | |
| Customer prepayments | $33.1M | $52.7M | |
| Accrued program costs | $52.2M | $69.4M | |
| Accrued expenses and other payables | $28.3M | $32.0M | |
| Operating lease liabilities, current | $5.8M | $6.1M | |
| Income taxes payable | $2.6M | $2.9M | |
| Total current liabilities | $209.4M | $232.3M | |
| Long-term debt | $174.0M | $147.3M | |
| Operating lease liabilities, long-term | $11.6M | $14.3M | |
| Deferred income tax liabilities | $8.2M | $8.0M | |
| Other liabilities | $923.0K | $1.6M | |
| Total liabilities | $404.1M | $403.6M | |
| Preferred stock, $0.10 par value per share; authorized 400,000 shares; none issued | $0 | $0 | |
| Common stock, $0.10 par value per share; authorized 40,000,000 shares; issued 34,923,562 shares in 2025 and 34,794,548 shares in 2024 | $3.5M | $3.5M | |
| Additional paid-in capital | $117.1M | $114.7M | |
| Accumulated other comprehensive loss | -$12.0M | -$18.7M | |
| Retained earnings | $155.0M | $204.9M | |
| Total stockholders' equity including treasury stock | $263.6M | $304.3M | |
| Less treasury stock at cost, 5,915,182 shares in 2025 and 5,915,182 in 2024 | -$71.2M | -$71.2M | |
| Total stockholders' equity | $192.4M | $233.1M | $370.0M |
| Total liabilities and stockholders' equity | $596.5M | $636.7M | |
| Allowance for doubtful accounts | $11.7M | $9.2M | |
| Preferred stock, par value per share | $0.10 | $0.10 | |
| Preferred stock, shares authorized | 400.0K shares | 400.0K shares | |
| Preferred stock, shares issued | 0 shares | 0 shares | |
| Common stock, par value per share | $0.10 | $0.10 | |
| Common stock, shares authorized | 40.0M shares | 40.0M shares | |
| Common stock, shares issued | 34.9M shares | 34.8M shares | |
| Treasury stock, shares | 5.9M shares | 5.9M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow in the latest annual report, as filed.3
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net (loss) income | -$49.9M | -$126.3M | $7.5M |
| Depreciation and amortization of property, plant and equipment and intangible assets | $18.7M | $22.3M | $21.8M |
| Amortization of other long-term assets | $21.0K | $226.0K | $1.8M |
| Amortization of deferred loan fees | $1.9M | $536.0K | $254.0K |
| Gain on disposal of property, plant and equipment | -$75.0K | -$1.0M | $0 |
| Impairment of assets | $25.4M | $50.4M | $0 |
| Provision for estimated credit losses | $2.4M | $2.3M | $1.9M |
| Stock-based compensation | $2.0M | $4.4M | $6.1M |
| Deferred income taxes | -$1.4M | $1.5M | -$9.7M |
| Changes in liabilities for uncertain tax positions or unrecognized tax benefits | -$201.0K | -$1.5M | -$508.0K |
| Change in equity investment fair value | $437.0K | $2.4M | $359.0K |
| Lease obligations and non-cash lease expense, net | -$147.0K | -$37.0K | $256.0K |
| Unrealized foreign currency transaction (gains) losses | -$193.0K | $804.0K | -$581.0K |
| Decrease (increase) in receivables | $7.7M | $7.5M | -$20.3M |
| Decrease (increase) in inventories | $6.3M | $35.2M | -$27.3M |
| Decrease (increase) in income tax receivable/payable | -$9.0K | -$3.8M | $3.6M |
| (Increase) decrease in prepaid expenses and other assets | -$8.6M | -$687.0K | $1.3M |
| Increase (decrease) in accounts payable | $15.4M | $3.7M | -$2.3M |
| Decrease in customer prepayments | -$19.6M | -$12.9M | -$45.1M |
| (Decrease) increase in accrued program costs | -$17.4M | $1.8M | $7.2M |
| (Decrease) increase in accrued expenses and other payables | -$4.0M | $17.2M | -$5.1M |
| Net cash (used in) provided by operating activities | -$21.2M | $3.9M | -$58.7M |
| Capital expenditures | -$3.9M | -$7.3M | -$11.9M |
| Proceeds from disposal of property, plant and equipment | $477.0K | $1.1M | $242.0K |
| Acquisitions of business and product line, net of cash acquired | $0 | $0 | -$5.2M |
| Intangible assets | -$165.0K | -$409.0K | -$186.0K |
| Net cash used in investing activities | -$3.6M | -$6.6M | -$17.0M |
| Payments under line of credit agreement | -$223.5M | -$294.4M | -$172.5M |
| Borrowings under line of credit agreement | $250.1M | $302.8M | $259.1M |
| Payment of deferred loan fees | -$3.4M | -$850.0K | $0 |
| Net receipt from the issuance of common stock under ESPP | $629.0K | $901.0K | $981.0K |
| Net (payment) receipt from the exercise of stock options | -$205.0K | $0 | $46.0K |
| Payment from common stock purchased for tax withholding | $0 | -$1.4M | -$2.0M |
| Repurchase of common stock | $0 | $0 | -$15.5M |
| Payment of cash dividends | $0 | -$2.5M | -$3.4M |
| Net cash provided by financing activities | $23.7M | $4.5M | $66.7M |
| Net increase (decrease) in cash | -$1.1M | $1.8M | -$9.0M |
| Effect of exchange rate changes on cash | $1.0M | -$742.0K | $116.0K |
Recent filings
- Oct 1, 20268-K
- Sep 30, 202610-K/A
- Aug 20, 20264
- Aug 18, 20264
- Aug 11, 20268-K
- Aug 10, 202610-Q
- Jul 14, 20264
- Jun 9, 20264
- Jun 8, 20264
- Jun 8, 20264
- Jun 8, 20268-K
- Jun 8, 20264
- Jun 8, 20264
- Jun 5, 20264
- Jun 5, 20264
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10